A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma

Department

Program

Citation of Original Publication

Gordon, Max J., Sigrid Dubois, Bonita Bryant, et al. “A Phase 1 Study of Interleukin-15 in Combination with Avelumab in Relapsed or Refractory T-Cell Lymphoma.” Leukemia & Lymphoma 65, no. 7 (2024): 1008–11. https://doi.org/10.1080/10428194.2024.2326847.

Rights

This work was written as part of one of the author's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.
Public Domain

Subjects

Abstract